Gapping up
In reaction to earnings/guidance:
- BOX +0.5%
Other news:
- LL +20.5% (F9 Investments prepared to consider an offer of $5.76/sh for LL)
- CCO +3.9% (closes sale of Italy business to JCDecaux SE (JCDXF) for approx. $16.2 mln (EUR15.1 mln))
- TWLO +3.7% (will lose supervoting protection next month; also co has been meeting with activist according to TheInformation)
- CAE +3% (awarded $455 mln subcontract for US Army Flight School)
- ANIK +2.1% (completes enrollment in Hyalofast phase 3 study)
- NAAS +2.1% (announces $21 million of registered direct offering to certain investors)
- IGMS +1.9% (announces FDA clearance to begin clinical studies of imvotamab in lupus and rheumatoid arthritis)
- SMTC +1.2% (names new CEO)
- SNY +1.1% (reports Phase 2 data of novel investigational anti-CD40L antibody frexalimab show significantly reduced disease activity in relapsing multiple sclerosis)
Analyst comments:
- CAR +4.1% (upgraded to Buy from Hold at Deutsche Bank)
- QTWO +2.9% (upgraded to Buy from Neutral at BTIG Research)